This is a single arm, open-label, phase II trial investigating the combination of ivonescimab with standard FOLFOX chemotherapy in 1L therapy for HER2- GEA.

Stomach Cancer Stage IVEsophagus CancerStomach Cancer

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT07070466

Observational

Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Patients with digestive tract malignancy often experience severe and unremitting abdominal pain that negatively affects physical, emotional, and social functio…

Cancer PainVisceral PainGastrointestinal Neoplasms+76 more

~Estimated

~$10 – $6,250

Cedars-Sinai Medical CenterNCT04907643